Literature DB >> 8466336

Surgical management of pulmonary infections in chronic granulomatous disease of childhood.

H W Pogrebniak1, J I Gallin, H L Malech, A R Baker, C A Moskaluk, W D Travis, H I Pass.   

Abstract

Chronic granulomatous disease of childhood is an inheritable disorder of phagocytic cell respiratory burst resulting in recurrent, life-threatening, catalase-positive infections. The lung is the most common site of infection, and pulmonary disease is the primary cause of death in greater than 50% of children with chronic granulomatous disease. Still, the role of surgery in management of this disease remains undefined. Between 1974 and 1990, 19 patients with chronic granulomatous disease required 31 thoracic interventions at our institution. Patients ranged in age from 2.5 to 27 years (mean age, 15 years). Seventeen of 19 patients (89%) had had previous pulmonary infections. Patients presented as toxic (temperature > 38.5 degrees C, chest pain, and cough) in 22 instances before the 31 procedures. Aggressive surgical intervention for diagnosis and extirpation of localized infections was undertaken with lobectomy/pneumonectomy with or without other procedures (5), bisegmentectomy (2), segmentectomy with or without other procedures (5), or wedge with or without other procedures (13). In five instances, an empyema was drained; a chest tube for a sterile collection was placed in one instance. There was one intraoperative death, and 3 patients died 22 to 600 days postoperatively with overwhelming sepsis. The mean hospitalization was 101 days (range, 24 to 600 days). Wound complications occurred in 5 patients, requiring 17 separate anesthetic debridements. A change in therapy was dictated by the results of the procedure in 23 of 31 instances (74%). Thoracic surgeons must be aware of this rare cause of immunosuppression in these children and, due to the unusual nature of the pulmonary infections, should follow an aggressive approach in their diagnosis and management.

Entities:  

Mesh:

Year:  1993        PMID: 8466336     DOI: 10.1016/0003-4975(93)90103-o

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience.

Authors:  Paul L Feingold; Humair S Quadri; Seth M Steinberg; Harry L Malech; John I Gallin; Christa S Zerbe; Kol A Zarember; Beatrice E Marciano; Steven M Holland; David S Schrump; Robert T Ripley
Journal:  J Clin Immunol       Date:  2016-08-06       Impact factor: 8.317

2.  Wedge resection for localized infectious lesions: high margin/lesion ratio guaranteed operational safety.

Authors:  Yifeng Sun; Likun Hou; Huikang Xie; Hui Zheng; Gening Jiang; Wen Gao; Chang Chen
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

3.  Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry.

Authors:  Meera Patrawala; Ying Cui; Limin Peng; Ramsay L Fuleihan; Elizabeth K Garabedian; Kiran Patel; Lokesh Guglani
Journal:  J Clin Immunol       Date:  2020-01-09       Impact factor: 8.317

4.  Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease.

Authors:  B H Segal; N Sakamoto; M Patel; K Maemura; A S Klein; S M Holland; G B Bulkley
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 5.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

6.  Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.

Authors:  H Sambatakou; M Guiver; D Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-18       Impact factor: 3.267

7.  Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999-2018).

Authors:  Qiong Yao; Qin-Hua Zhou; Quan-Li Shen; Zhong-Wei Qiao; Xiao-Chuan Wang; Xi-Hong Hu
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.